Chemotherapy use near the end-of-life in patients with metastatic breast cancer

INTRODUCTION: Very few data are available regarding the use of chemotherapy in patients with metastatic breast cancer (MBC) near the end-of-life, i.e., the final month. The aim of this study was to provide a descriptive analysis of its use in two different European geographic areas (Sweden and Greec...

Descripción completa

Detalles Bibliográficos
Autores principales: Edman Kessler, Luisa, Sigfridsson, Johnny, Hatzidaki, Dora, Bergh, Jonas, Foukakis, Theodoros, Georgoulias, Vasilios, Matikas, Alexios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Clinical Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220858/
https://www.ncbi.nlm.nih.gov/pubmed/32383058
http://dx.doi.org/10.1007/s10549-020-05663-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220858/
https://www.ncbi.nlm.nih.gov/pubmed/32383058
http://dx.doi.org/10.1007/s10549-020-05663-w

Ejemplares similares